Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
Martín Knapp(London School of Economics and Political Science), Robert Howard(University College London), Cornelius Katona(University College London), John T. O’Brien(North Tyneside General Hospital), Patrick Phillips(Unknown), Robert Barber(University of North Texas), Alistair Burns(University of Manchester), Clive Ballard(University of Exeter), Sube Banerjee(University of Nottingham), James Lindesay(University of Leicester), Rupert McShane(Oxford Health NHS Foundation Trust), Tom Dening(University of Nottingham), Bart Sheehan(University of Warwick), Richard G. Brown(Imperial College London), Peter Bentham(Queen Elizabeth Hospital Birmingham), Derek King(London School of Economics and Political Science), Ashley Baldwin(Whiston Hospital), Clive Holmes(University of Eastern Finland), David M. Findlay(The University of Adelaide), Robert Jones(University of Nottingham), Ajay Macharouthu(Crichton Royal Hospital), Tony Johnson(University of Liverpool), Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), Jessica Adams, Renée Romeo(King's College London)
Cited by 63
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k